Huang Jane — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Huang Jane has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Profile

Huang Jane

Jane Huang is the President and Chief Medical Officer of Prelude Therapeutics Inc, a clinical stage precision oncology company. She has been involved in the development of therapies targeting key mechanisms in cancer treatment.

RoleInsider
Notability30/100

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2025-10-04PRLDPrelude Therapeutics IncF — Tax withholding / forfeiture3.4K$1.47$5K
2025-10-04PRLDPrelude Therapeutics IncM — Option exercise9.4K—
2025-07-04PRLDPrelude Therapeutics IncF — Tax withholding / forfeiture3.4K$0.79$3K
2025-07-04PRLDPrelude Therapeutics IncM — Option exercise9.4K—
2024-10-07PRLDPrelude Therapeutics IncF — Tax withholding / forfeiture3.3K$2.00$7K
2024-10-07PRLDPrelude Therapeutics IncM — Option exercise9.4K—

Companies — Last 90 Days

Frequently Asked Questions

Who is Huang Jane?

Jane Huang is the President and Chief Medical Officer of Prelude Therapeutics Inc, a clinical stage precision oncology company. She has been involved in the development of therapies targeting key mechanisms in cancer treatment.…

How many SEC Form 4 filings has Huang Jane submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Where can I see all of Huang Jane's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Huang Jane profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.